Lv31
246 积分 2025-03-20 加入
Application of HepaSH cells for predicting cholestatic drug-induced liver injury via bile acid-dependent toxicity assay
1小时前
已完结
Reproducing human and cross-species drug toxicities using a Liver-Chip
1小时前
已完结
An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIII
19天前
已完结
Introduction to the 3RsC's Cross-Platform Microphysiological Systems Evaluation for Drug-Induced Liver Injury in Collaboration with FDA-CDER
21天前
已关闭
Introduction to the 3RsC's Cross-Platform Microphysiological Systems Evaluation for Drug-Induced Liver Injury in Collaboration with FDA-CDER
23天前
已完结
Human organoids: model systems for human biology and medicine
26天前
已完结
R&D efficiency of leading pharmaceutical companies – A 20-year analysis
2个月前
已完结
Analysis of pharma R&D productivity – a new perspective needed
2个月前
已完结
The pharmaceutical productivity gap – Incremental decline in R&D efficiency despite transient improvements
2个月前
已完结
Diagnosing the decline in pharmaceutical R&D efficiency
2个月前
已完结
皖公网安备34019202002308
